2021
-
Bronchoscopic Ablation: A Small Step for Heat Therapy, a Giant Leap for Lung Cancer
Surgery has long been the gold standard for diagnosis and management of early-stage operable lung cancer. For patients with inoperable disease or more extensive disease, however, alternative approaches are emerging. […]
-
Prof. Fabrice Barlesi Appointed Chief Executive Officer of Gustave Roussy for a Term of 5 years
Prof. Fabrice Barlesi has been appointed as chief executive officer of Gustave Roussy for a term of 5 years. Prof. Barlesi has been medical director and clinical research director there […]
-
David R. Gandara, MD, Appointed Chief Medical Officer (CMO) of the International Society for Liquid Biopsy (ISLB)
David R. Gandara, MD, has been appointed chief medical officer (CMO) of the International Society for liquid biopsy (ISLB), an international nonprofit organization dedicated to advancing the field of liquid […]
-
The IASLC Supports International Day for Clean Air for Blue Skies “Healthy Air, Healthy Planet” Campaign
The International Association for the Study of Lung Cancer (IASLC)—as an international organization of lung cancer experts who serves patients in both developed and developing countries, as well as vulnerable […]
-
Narjust Duma Moves to Dana-Farber Cancer Institute
Narjust Duma, MD, has been named associate director of the Cancer Care Equity Program and assistant professor of medicine at Dana-Farber Cancer Institute/Harvard Medical School. She will develop strategies to […]
-
Gemcitabine: A New Chemotherapy Partner for Immune Checkpoint Inhibitors? Insights From the ORIENT-12 Study
Squamous cell lung cancer (SqCLC), which accounts for approximately 25% to 30% of all lung cancer cases, is the second-most prevalent histologic subtype of NSCLC. Its distinct clinicopathologic and molecular […]
-
Peter Bach, MD, is the New Chief Medical Officer at Delfi Diagnostic
Peter Bach, MD, is the new chief medical officer at Delfi Diagnostics, a developer of blood tests for early detection of multiple types of cancer. Dr. Bach leaves Memorial Sloan […]
-
Joshua Bauml, MD, moves to The Janssen Pharmaceutical Companies of Johnson & Johnson
Joshua Bauml, MD, has moved to The Janssen Pharmaceutical Companies of Johnson & Johnson from the University of Pennsylvania. Dr. Bauml was with the University of Pennsylvania for a decade—2 […]
-
Jean-Charles Soria, MD, PhD Joins Amgen
Jean-Charles Soria, MD, PhD, joined Amgen in early August 2021 as senior vice president of the oncology therapeutic sector. Prof. Soria, previously served as senior vice president of Research & […]
-
Suresh S. Ramalingam, MD, Appointed Executive Director of the Winship Cancer Institute and Associate Vice-President for Cancer at the Woodruff Health Sciences Center of Emory University
Suresh S. Ramalingam, MD, was appointed as the executive director of the Winship Cancer Institute and Associate Vice-President for Cancer at the Woodruff Health Sciences Center of Emory University on […]
View ILCN Archives
Provider Resources